Gene Therapy Clinical Trial
Official title:
Growth and Development, Health-related Quality of Life of Children With Transfusion-dependent Beta-thalassemia After Gene Therapy
The investigate will conduct a cohort study to compare the growth and development, metabolism, lifestyle behavior, and health-related quality of life among three groups: children with transfusion-dependent β-thalassemia (TDT) who have received gene therapy, TDT children with lifelong supportive therapy and healthy children.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03306277 -
Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1
|
Phase 3 | |
| Recruiting |
NCT04286815 -
Gene Therapy for X Linked Severe Combined Immunodeficiency
|
N/A | |
| Recruiting |
NCT04728841 -
Gene Therapy for Chinese Hemophilia A
|
N/A | |
| Withdrawn |
NCT04358471 -
Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)
|
Phase 2 | |
| Recruiting |
NCT01166009 -
CIBMTR Research Database
|
||
| Completed |
NCT03734588 -
Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03311503 -
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05044845 -
Needs Assessment of Knowledge, Beliefs, and Attitudes of Patients With Hemophilia B About Gene Therapy
|
||
| Completed |
NCT01024998 -
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
|
Phase 1 | |
| Enrolling by invitation |
NCT05210803 -
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
|
||
| Active, not recruiting |
NCT03520712 -
Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5
|
Phase 1/Phase 2 |